Physician profile
Senthil Kumar Sivalingam
NPI 1801084793
$29,579.40
in general payments reported to CMS, 2019-2025
27 companies · $8,235 in 2025
The $8,235 reported for 2025 was more than what 76% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,694 · 2020: $1,314 · 2021: $799 · 2022: $711 · 2023: $1,868 · 2024: $15K · 2025: $8,235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $9,329 · Travel and Lodging: $4,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,200.00 |
| Food and Beverage | $9,329.17 |
| Travel and Lodging | $4,532.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $21,429.24 | 2021-2025 | Azure Xt Dr Mri Surescan, Pulseselect, Micra |
| Abbott Laboratories | $2,064.81 | 2019-2025 | Gallant, Aveir, Ensite Precision |
| Medtronic Vascular, INC. | $1,345.09 | 2019-2020 | |
| Medical Device Business Services, INC. | $807.87 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $596.04 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $503.43 | 2019-2025 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor, S-Icd System Magnet |
| Biosense Webster, INC. | $485.68 | 2020-2025 | Qdot Micro, Carto 3 |
| Medicomp INC | $395.08 | 2021-2025 | Telepatch Cardiac Monitor |
| Novartis Pharmaceuticals Corporation | $329.08 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $248.90 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $201.36 | 2021-2025 | Farxiga |
| Amgen INC. | $156.00 | 2023-2025 | Repatha, Repatha |
| Novo Nordisk INC | $145.45 | 2024-2025 | Wegovy |
| Cordis US Corp. | $136.30 | 2025 | Mynx Control Venous |
| Biotronik INC. | $120.71 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Altathera Pharmaceuticals LLC | $83.20 | 2023 | Sotalol Hydrochloride |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.91 | 2023-2024 | Jardiance |
| Pfizer INC. | $73.85 | 2024-2025 | |
| Itamar Medical INC | $72.04 | 2023 | Watchpatone |
| E.R. Squibb & Sons, L.L.C. | $62.24 | 2023-2024 | Eliquis, Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $58.04 | 2022-2025 | |
| Atricure, INC. | $46.21 | 2020 | |
| W. L. Gore & Associates, INC. | $39.51 | 2024 | Gore Excluder Aaa Endoprosthesis |
| Alnylam Pharmaceuticals INC. | $37.16 | 2023 | Onpattro |
| Elutia, INC. | $33.07 | 2023-2025 | Ecm Patch,Pouch |
| Esperion Therapeutics, INC. | $16.45 | 2024 | Nexletol |
| Cardiva Medical, INC. | $14.68 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Senthil Sivalingam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.